DE60328979D1 - Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum - Google Patents

Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum

Info

Publication number
DE60328979D1
DE60328979D1 DE60328979T DE60328979T DE60328979D1 DE 60328979 D1 DE60328979 D1 DE 60328979D1 DE 60328979 T DE60328979 T DE 60328979T DE 60328979 T DE60328979 T DE 60328979T DE 60328979 D1 DE60328979 D1 DE 60328979D1
Authority
DE
Germany
Prior art keywords
androgen
regulated
gene
cancer growth
inhibit cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60328979T
Other languages
English (en)
Inventor
Shiv Srivastava
Judd W Moul
Linda L Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Application granted granted Critical
Publication of DE60328979D1 publication Critical patent/DE60328979D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE60328979T 2002-05-10 2003-05-09 Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum Expired - Lifetime DE60328979D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37894902P 2002-05-10 2002-05-10
PCT/US2003/013401 WO2003095611A2 (en) 2002-05-10 2003-05-09 Androgen-regulated pmepa1 and cancer

Publications (1)

Publication Number Publication Date
DE60328979D1 true DE60328979D1 (de) 2009-10-08

Family

ID=29420458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60328979T Expired - Lifetime DE60328979D1 (de) 2002-05-10 2003-05-09 Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum

Country Status (7)

Country Link
EP (1) EP1503780B1 (de)
JP (1) JP4744140B2 (de)
AT (1) ATE440613T1 (de)
AU (1) AU2003231196C1 (de)
CA (1) CA2485138C (de)
DE (1) DE60328979D1 (de)
WO (1) WO2003095611A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023097293A2 (en) * 2021-11-23 2023-06-01 President And Fellows Of Harvard College Anti-pmepa-1 antibodies or antigen binding fragments thereof, compositions, and uses thereof
CN114524872A (zh) * 2022-03-09 2022-05-24 广州诺诚生物技术研发有限公司 一种用于乳腺癌检测的单克隆抗体及其试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
ES2118066T3 (es) 1989-10-05 1998-09-16 Optein Inc Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5840507A (en) * 1997-03-19 1998-11-24 Oncotech, Inc. Methods for cancer prognosis and diagnosis
US6268377B1 (en) * 1998-09-28 2001-07-31 Merck & Co., Inc. Method for treating androgen-related conditions
EP1165605A1 (de) * 1999-02-24 2002-01-02 Trustees Of Tufts College Androgen-induzierte suppression von zellvermehrung und verwendungen davon
JP2002539773A (ja) 1999-03-01 2002-11-26 ミレニウム ファーマシューティカルズ，インコーポレーテッド 分泌タンパク質およびそれらをコードする核酸
US6566130B1 (en) * 2000-01-28 2003-05-20 Henry M. Jackson Foundation For The Advancement Of Military Medicine Androgen-regulated gene expressed in prostate tissue
MXPA03003151A (es) * 2000-10-13 2003-08-19 Eos Biotechnology Inc Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata.

Also Published As

Publication number Publication date
AU2003231196C1 (en) 2009-05-21
AU2003231196A1 (en) 2003-11-11
WO2003095611A3 (en) 2004-09-23
CA2485138C (en) 2015-04-28
AU2003231196B2 (en) 2008-05-01
JP4744140B2 (ja) 2011-08-10
CA2485138A1 (en) 2003-11-20
EP1503780A2 (de) 2005-02-09
WO2003095611A2 (en) 2003-11-20
EP1503780B1 (de) 2009-08-26
ATE440613T1 (de) 2009-09-15
JP2006508031A (ja) 2006-03-09
EP1503780A4 (de) 2006-01-18

Similar Documents

Publication Publication Date Title
ATE303445T1 (de) Verfahren zur regulation der transkription von fremden genen in gegenwart von stickstoff
DE60038951D1 (de) Verfahren zur inhibierung von gehirntumorwachstum durch verwendung von antagonisten von integrinen
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
IL157756A (en) Methods for assaying activity of trancriptional control elements
ATE513911T1 (de) Verfahren und zusammensetzungen für rna- interferenz
ATE498685T1 (de) Antisense-oligonukleotide zur induktion von exon- skipping sowie verfahren zur verwendung davon
BRPI0403169A (pt) Prognósticos de câncer colorretal
DE60236921D1 (de) Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor
DE60225312D1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
ATE421574T1 (de) Zellkulturmethode zur erzeugung von prostata- ähnlichen acini
ATE387220T1 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
ATE489478T1 (de) Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation
DE60328979D1 (de) Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum
DE602004032114D1 (de) Rna-interferenz für das gen znfn3a1 als verfahren zur hemmung des wachstums von krebszellen
Knirsh et al. Loss of E-cadherin–mediated cell–cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-Jun
ATE329055T1 (de) Methode zur erstellung von genexpressionsprofilen
DE60137721D1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
ATE339208T1 (de) Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs
DE10345021A1 (de) Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
ATE533779T1 (de) Isoliertes photoprotein mtclytin, sowie dessen verwendung
ATE391727T1 (de) Verfahren zur identifikation von modulatoren des humanen orexin-2-rezeptors
DE60327449D1 (de) Zusammensetzungen zur hemmung der proliferation und infiltration von gehirntumorzellen durch expression der ampa-typ glutamat-rezeptor-untereinheit
DE60306636D1 (de) Wachstumhormonsekretionsförderer
WO2005017112A3 (en) Methods of inhibiting cancer growth by binding to nuclear receptors
WO2004005462A3 (en) Reagents and methods for identifying and modulating expression of tumor senescence genes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition